Phosco Ltd

Basic Materials AU PHO

0.125AUD
-0.005(3.85%)

Last update at 2026-03-10T01:11:00Z

Day Range

0.120.12
LowHigh

52 Week Range

0.050.17
LowHigh

Fundamentals

  • Previous Close 0.13
  • Market Cap65.58M
  • Volume146521
  • P/E Ratio-
  • Dividend Yield-%
  • EBITDA-3.27491M
  • Revenue TTM0.04M
  • Revenue Per Share TTM-
  • Gross Profit TTM 0.00000M
  • Diluted EPS TTM-0.02

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Financials

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2025-06-30 2024-06-30 2023-06-30 2022-06-30 2021-06-30
Type yearly yearly yearly yearly yearly
Date 2025-06-30 2024-06-30 2023-06-30 2022-06-30 2021-06-30
Income before tax -6.78205M -1.97700M -8.77200M -1.29500M -1.13230M
Minority interest - 0.24M 2.41M - -
Net income -6.89865M -1.73500M -6.36600M -1.29600M -1.13230M
Selling general administrative 1.99M 0.97M 1.61M 0.94M 0.79M
Selling and marketing expenses - 0.56M 1.71M 0.71M 0.00001M
Gross profit -0.03435M -0.01233M -0.00861M -0.00950M -0.18436M
Reconciled depreciation - 0.01M 0.00861M 0.00950M -
Ebit -2.85544M -1.53833M -8.47461M -1.66650M -1.14305M
Ebitda -2.82109M -1.52600M -8.46600M -1.65700M -1.14305M
Depreciation and amortization 0.03M 0.01M 0.00861M 0.00950M 0.00113M
Non operating income net other - - - - -
Operating income -3.30925M -1.52600M -3.33400M -1.66700M -1.14305M
Other operating expenses 3.31M 1.53M 3.33M 1.67M 1.14M
Interest expense 3.93M 0.69M 0.30M 0.24M 0.00000M
Tax provision 0.00000M 0.00000M 0.00052M 0.00045M 0.00000M
Interest income 3.47M 0.01M 0.32M 0.37M 0.00112M
Net interest income - -0.67979M -0.25921M -0.23853M 0.00112M
Extraordinary items - - - - -
Non recurring - - - - -
Other items - - - - -
Income tax expense - -0.25467M 0.00052M 0.00045M -0.00225M
Total revenue 0.00067M 0.01M 0.04M 0.00019M 0.00112M
Total operating expenses 3.27M 1.53M 3.33M 1.66M 1.14M
Cost of revenue 0.03M 0.01M 0.00861M 0.00950M 0.19M
Total other income expense net -3.47280M -0.45200M -5.44600M 0.37M 0.00962M
Discontinued operations - - - - -
Net income from continuing ops - -1.97724M -8.77215M -1.29558M -1.13230M
Net income applicable to common shares -6.89865M -1.73490M -6.36647M -1.21951M -1.13230M
Preferred stock and other adjustments - - - - -
Breakdown 2025-06-30 2024-06-30 2023-06-30 2022-06-30 2021-06-30
Type yearly yearly yearly yearly yearly
Date 2025-06-30 2024-06-30 2023-06-30 2022-06-30 2021-06-30
Total assets 4.38M 0.78M 1.43M 6.19M 0.67M
Intangible assets - - - - -
Earning assets - - - - -
Other current assets 0.10M 0.18M 0.20M 0.18M 0.02M
Total liab 9.90M 9.45M 2.27M 7.55M 0.62M
Total stockholder equity 1.24M -2.36957M -0.83987M 2.22M 0.05M
Deferred long term liab - - - - -
Other current liab 4.57M 0.58M 0.73M 0.85M 0.52M
Common stock 68.73M 60.33M 59.93M 56.80M 53.51M
Capital stock - - 59.93M 56.80M 53.51M
Retained earnings -69.42125M -62.52260M -61.03458M -54.98788M -53.79857M
Other liab - - - - -
Good will - - - - -
Other assets - - - - -
Cash 3.46M 0.55M 1.19M 1.81M 0.58M
Cash and equivalents - - 1.19M 1.81M 0.58M
Total current liabilities 9.90M 9.45M 8.22M 7.55M 0.62M
Current deferred revenue - 0.21M - - -
Net debt 0.65M 7.06M 4.97M 3.72M -0.57502M
Short term debt 4.11M 7.60M 6.16M 5.53M 0.00000M
Short long term debt - - 6.16M 5.53M -
Short long term debt total 4.11M 7.60M - 5.53M -
Other stockholder equity - -0.00000M 0.27M 0.41M 0.34M
Property plant equipment - - 0.02M 4.05M 0.04M
Total current assets 3.59M 0.72M 1.40M 2.13M 0.64M
Long term investments - - - - -
Net tangible assets - - -0.83987M 2.22M 0.05M
Short term investments - - - - -
Net receivables 0.04M 0.03M 0.02M 0.15M 0.01M
Long term debt - - - - -
Inventory - -0.02874M - - 0.03M
Accounts payable 1.22M 1.06M 1.09M 1.18M 0.10M
Total permanent equity - - - - -
Noncontrolling interest in consolidated entity - - - - -
Temporary equity redeemable noncontrolling interests - - - - -
Accumulated other comprehensive income 1.93M -0.17869M - 0.41M 0.34M
Additional paid in capital - - - - -
Common stock total equity - - - - -
Preferred stock total equity - - - - -
Retained earnings total equity - - - - -
Treasury stock - - - - -
Accumulated amortization - - - - -
Non currrent assets other 0.54M - - - -
Deferred long term asset charges - - - - -
Non current assets total 0.78M 0.06M 0.02M 4.05M 0.04M
Capital lease obligations - - - - -
Long term debt total - - 0.00000M 0.00000M 0.00000M
Breakdown 2025-06-30 2024-06-30 2023-06-30 2022-06-30 2021-06-30
Type yearly yearly yearly yearly yearly
Date 2025-06-30 2024-06-30 2023-06-30 2022-06-30 2021-06-30
Investments - -0.05417M -0.00702M -0.43995M -
Change to liabilities - - 0.16M 0.11M -0.02626M
Total cashflows from investing activities -0.78104M -0.05417M -0.00702M -0.43995M -0.43995M
Net borrowings - - - - -
Total cash from financing activities 5.51M 0.90M 2.89M 3.26M 3.26M
Change to operating activities - - 0.11M 0.07M 0.00309M
Net income -6.89865M -1.73490M -6.36647M -1.21951M -1.13230M
Change in cash 2.91M -0.63955M -0.60474M 1.22M -0.98692M
Begin period cash flow 0.55M 1.19M 1.81M 0.58M 1.56M
End period cash flow 3.46M 0.55M 1.19M 1.79M 0.58M
Total cash from operating activities -1.91593M -1.48885M -3.46933M -1.56221M -0.98388M
Issuance of capital stock - 1.00M 2.90M 3.43M -
Depreciation 0.03M 0.01M 4.52M 0.00950M 0.00950M
Other cashflows from investing activities - - - - -
Dividends paid - - - - -
Change to inventory - - - - -
Change to account receivables 0.07M 0.00909M 0.09M -0.08583M -0.01598M
Sale purchase of stock - -0.09650M -0.01822M -0.16861M 0.00000M
Other cashflows from financing activities - 0.09M -0.00702M -0.43995M -0.16861M
Change to netincome - - -1.98152M -0.44576M 0.19M
Capital expenditures 0.36M 0.05M 0.00702M 0.44M 0.00000M
Change receivables - - - - -
Cash flows other operating - - - - -
Exchange rate changes - - - - -
Cash and cash equivalents changes - - - - -
Change in working capital 0.68M 0.12M 0.36M 0.09M -0.13598M
Stock based compensation - 0.02M 0.09M - 0.28M
Other non cash items 4.27M 0.09M -1.98152M -0.44576M 0.28M
Free cash flow -2.27671M -1.54302M -3.47636M -2.00216M -0.98388M

Peer Comparison

Sector: Basic Materials Industry: Other Industrial Metals & Mining

Company Change (AUD) Price (AUD) Trailing PE (x) Forward PE (x) Price Sales TTM (x) Price to Book Value (x) Enterprise Value to EBITDA (x)
PHO
Phosco Ltd
-0.005 3.85% 0.12 - - 461.14 52.95 -3.2712
BHP
BHP Group Ltd
0.73 1.42% 51.96 19.49 16.61 5.19 4.10 4.09 7.62
RIO
RIO Tinto Ltd
1.69 1.10% 155.30 18.36 19.30 4.47 3.03 3.55 8.90
FMG
Fortescue Ltd
0.71 3.68% 19.98 11.34 14.14 3.65 2.05 2.69 5.24
S32
SOUTH32 Ltd
0.10 2.35% 4.36 38.42 16.08 3.50 1.56 2.54 11.29

Reports Covered

Stock Research & News

Profile

PhosCo Ltd, together with its subsidiaries, engages in the exploration, development, and realization of mineral resource projects in North Africa. It explores for zinc, gold, base and precious metals, and lead deposits. The company holds 100% interest in the Gasaat Phosphate project that covering approximately 112 square kilometers located in Tunisia; the Sekarna Phosphate project that covering 60 square kilometers located 10 kilometers to the southwest of Sekarna; and the Green Shift project. It also holds a portfolio of exploration permits and applications in Northern and Central Tunisia. The company was formerly known as Celamin Holdings Limited and changed its name to PhosCo Ltd in January 2022. PhosCo Ltd was incorporated in 2009 and is based in South Melbourne, Australia.

Phosco Ltd

385 Bourke Street, Melbourne, VIC, Australia, 3000

Key Executives

Name Title Year Born
Mr. Simon Peter Eley B.A., L.L.B. MD, CEO & Exec. Director 1973
Mr. Craig K. Smyth BCA (Acctg), C.A., CA, L.L.B., M App Fin CFO & Director 1973
Mr. Tarecq Elias Aldaoud BPHARM Exec. Director NA
Mr. Stefan Ross Company Sec. NA
Mr. Russell Luxford Technical Advisor NA
Mr. Simon Peter Eley B.A., L.L.B. MD, CEO & Executive Director 1973
Mr. Tarecq Elias Aldaoud BPHARM Executive Director NA
Mr. Stefan Ross Company Secretary NA
Mr. Simon Peter Eley B.A., L.L.B. MD, CEO & Executive Director 1973
Mr. Tarecq Elias Aldaoud BPHARM Executive Director NA

Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.